Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2023; 18(03): 597-601
DOI: 10.1055/s-0043-1774395
Research Article

Ventriculoperitoneal Shunt Surgery in Brunei Darussalam: A Population-Based Perspective

Merlin Boban
1   Department of Neurosurgery, Brunei Neuroscience, Stroke and Rehabilitation Centre, Pantai Jerudong Specialist Centre, Jerudong, Brunei Darussalam
,
John Mathew
1   Department of Neurosurgery, Brunei Neuroscience, Stroke and Rehabilitation Centre, Pantai Jerudong Specialist Centre, Jerudong, Brunei Darussalam
,
Ady Thien
1   Department of Neurosurgery, Brunei Neuroscience, Stroke and Rehabilitation Centre, Pantai Jerudong Specialist Centre, Jerudong, Brunei Darussalam
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Corrected by:

Erratum: Ventriculoperitoneal Shunt Surgery in Brunei Darussalam: A Population-Based PerspectiveAsian J Neurosurg 2023; 18(03): e1-e1
DOI: 10.1055/s-0043-1776296

Abstract

Objective Ventriculoperitoneal shunt surgery is commonly performed to treat hydrocephalus. We aimed to characterize the demographics, complications, and outcomes of patients who underwent ventriculoperitoneal shunt surgery in Brunei Darussalam.

Materials and Methods We conducted a retrospective study on patients who underwent ventriculoperitoneal shunt surgery at the Neurosurgery Department of the Raja Isteri Pengiran Anak Saleha Hospital and Brunei Neuroscience Stroke and Rehabilitation Centre between January 2015 and June 2020.

Statistical Analysis All statistical analyses were performed using the Statistical Package for the Social Sciences version 20 (IBM Corporation, Armonk, New York, United States). The χ2 test, Student's t-test, and Mann–Whitney U test were performed for nominal, normally, and non-normally distributed variables, respectively. Multivariate logistic regression was used to assess the predictors of complications and shunt failure.

Results Fifty-three patients with a median age of 33 (interquartile range, 4–49) years were included. A total of 53 shunt operations were performed: 18 in the pediatric population and 35 in adults. The overall complication rate was 22.6%. Infection was the most common (9.4%) complication, with coagulase-negative staphylococci being the common organism causing the infection. The shunt failure rate (defined as removal or revision) was 20.8%. Univariate and multivariate analyses did not identify factors associated with complications or shunt failure.

Conclusion Ventriculoperitoneal shunt surgery, a common and technically non-demanding neurosurgical procedure, is associated with significant complications. We highlighted that shunt infection remains a concern and advocate practices to negate this risk.

Keywords

cerebrospinal fluid - complications - infection - hydrocephalus - ventriculoperitoneal shunt

Ethics

The study was approved by the local ethics committee and conducted in accordance with the ethical principles outlined by the Declaration of Helsinki.




Publication History

Article published online:
13 September 2023

© 2023. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kahle KT, Kulkarni AV, Limbrick Jr DD, Warf BC. Hydrocephalus in children. Lancet 2016; 387 (10020): 788-799
    CrossrefPubMedSearch in Google Scholar
  • 2 Isaacs AM, Riva-Cambrin J, Yavin D. et al. Age-specific global epidemiology of hydrocephalus: systematic review, metanalysis and global birth surveillance. PLoS One 2018; 13 (10) e0204926
    CrossrefPubMedSearch in Google Scholar
  • 3 Ames RH. Ventriculo-peritoneal shunts in the management of hydrocephalus. J Neurosurg 1967; Dec; 27 (06) 525-529
    CrossrefPubMedSearch in Google Scholar
  • 4 Nulsen FE, Spitz EB. Treatment of hydrocephalus by direct shunt from ventricle to jugular vain. Surg Forum 1951; 399-403
    PubMedSearch in Google Scholar
  • 5 Baru JS, Bloom DA, Muraszko K, Koop CE. John Holter's shunt. J Am Coll Surg 2001; 192 (01) 79-85
    CrossrefPubMedSearch in Google Scholar
  • 6 Reddy GK, Bollam P, Caldito G. Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus. World Neurosurg 2014; 81 (02) 404-410
    CrossrefPubMedSearch in Google Scholar
  • 7 Drake JM, Kestle JR, Milner R. et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998; 43 (02) 294-303 , discussion 303–305
    CrossrefPubMedSearch in Google Scholar
  • 8 Fernández-Méndez R, Richards HK, Seeley HM, Pickard JD, Joannides AJ. UKSR collaborators. Current epidemiology of cerebrospinal fluid shunt surgery in the UK and Ireland (2004-2013). J Neurol Neurosurg Psychiatry 2019; 90 (07) 747-754
    CrossrefPubMedSearch in Google Scholar
  • 9 Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002; 21 (07) 632-636
    CrossrefPubMedSearch in Google Scholar
  • 10 Richards H. The UK Shunt Registry. In: Malluci CL, Sgouros S. eds. Cerebrospinal Fluid Disorders. New York: Informa Healthcare; 2010: 494-495
    Search in Google Scholar
  • 11 Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006; 22 (07) 692-697
    CrossrefPubMedSearch in Google Scholar
  • 12 Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992; 77 (06) 875-880
    CrossrefPubMedSearch in Google Scholar
  • 13 Thomas R, Lee S, Patole S, Rao S. Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis. Br J Neurosurg 2012; 26 (02) 175-184
    CrossrefPubMedSearch in Google Scholar
  • 14 Kandasamy J, Dwan K, Hartley JC. et al. Antibiotic-impregnated ventriculoperitoneal shunts–a multi-centre British Paediatric Neurosurgery Group (BPNG) study using historical controls. Childs Nerv Syst 2011; 27 (04) 575-581
    CrossrefPubMedSearch in Google Scholar
  • 15 Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 2008; 24 (05) 557-562
    CrossrefPubMedSearch in Google Scholar
  • 16 Fichtner J, Güresir E, Seifert V, Raabe A. Efficacy of silver-bearing external ventricular drainage catheters: a retrospective analysis. J Neurosurg 2010; 112 (04) 840-846
    CrossrefPubMedSearch in Google Scholar
  • 17 Lackner P, Beer R, Broessner G. et al. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 2008; 8 (03) 360-365
    CrossrefPubMedSearch in Google Scholar
  • 18 Farber SH, Parker SL, Adogwa O, Rigamonti D, McGirt MJ. Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients. World Neurosurg 2010; 74 (4-5): 528-531
    CrossrefPubMedSearch in Google Scholar
  • 19 Parker SL, McGirt MJ, Murphy JA, Megerian JT, Stout M, Engelhart L. Cost savings associated with antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus. World Neurosurg 2015; 83 (03) 382-386
    CrossrefPubMedSearch in Google Scholar
  • 20 Edwards NC, Engelhart L, Casamento EM, McGirt MJ. Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus. J Neurosurg 2015; 122 (01) 139-147
    CrossrefPubMedSearch in Google Scholar
  • 21 Root BK, Barrena BG, Mackenzie TA, Bauer DF. Antibiotic impregnated external ventricular drains: meta and cost analysis. World Neurosurg 2016; 86: 306-315
    CrossrefPubMedSearch in Google Scholar
  • 22 Klimo Jr P, Thompson CJ, Ragel BT, Boop FA. Antibiotic-impregnated shunt systems versus standard shunt systems: a meta- and cost-savings analysis. J Neurosurg Pediatr 2011; 8 (06) 600-612
    CrossrefPubMedSearch in Google Scholar
  • 23 Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 2010; 66 (02) 284-289 , discussion 289
    CrossrefPubMedSearch in Google Scholar
  • 24 Mallucci CL, Jenkinson MD, Conroy EJ. et al; BASICS Study collaborators. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation. Lancet 2019; 394 (10208): 1530-1539
    CrossrefPubMedSearch in Google Scholar
  • 25 Farahmand D, Hilmarsson H, Högfeldt M, Tisell M. Perioperative risk factors for short term shunt revisions in adult hydrocephalus patients. J Neurol Neurosurg Psychiatry 2009; 80 (11) 1248-1253
    CrossrefPubMedSearch in Google Scholar
  • 26 Lee L, King NK, Kumar D. et al. Use of programmable versus nonprogrammable shunts in the management of hydrocephalus secondary to aneurysmal subarachnoid hemorrhage: a retrospective study with cost-benefit analysis. J Neurosurg 2014; 121 (04) 899-903
    CrossrefPubMedSearch in Google Scholar